G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 81 filers reported holding G1 THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,055,434 | -7.1% | 423,869 | 0.0% | 0.04% | -4.7% |
| Q1 2023 | $1,135,969 | -50.6% | 423,869 | 0.0% | 0.04% | -50.6% |
| Q4 2022 | $2,301,609 | -56.5% | 423,869 | 0.0% | 0.09% | -59.9% |
| Q3 2022 | $5,294,000 | +152.8% | 423,869 | 0.0% | 0.22% | +164.6% |
| Q2 2022 | $2,094,000 | -35.0% | 423,869 | 0.0% | 0.08% | -27.4% |
| Q1 2022 | $3,221,000 | -25.6% | 423,869 | 0.0% | 0.11% | -18.7% |
| Q4 2021 | $4,328,000 | -48.3% | 423,869 | -32.1% | 0.14% | -48.5% |
| Q3 2021 | $8,379,000 | -38.8% | 624,369 | 0.0% | 0.27% | -39.3% |
| Q2 2021 | $13,699,000 | +45.3% | 624,369 | +59.4% | 0.44% | +37.3% |
| Q1 2021 | $9,426,000 | – | 391,754 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |